Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Pettit

Showing results (201-210 of 659) with videos related to

Pageof 66
Sort By:
Journal of Chemotherapy (Florence, Italy)|March 18, 2008
In vitro interactions of approved and experimental drugs against Candida drugs against Candida sppK K Repp, F Hogan, G R Pettit, et al.
Molecular Pharmacology|March 1, 1997
Bryostatin 1 and phorbol ester down-modulate protein kinase C-alpha and -epsilon via the ubiquitin/proteasome pathway in human fibroblastsH W Lee, L Smith, G R Pettit, et al.
Anticancer Research|June 6, 1998
Dolastatin 15 induces apoptosis and BCL-2 phosphorylation in small cell lung cancer cell linesM A Ali, R Rosati, G R Pettit, et al.
Cancer Investigation|February 2, 2026
Low Cancer Screening Rates Among Emergency Department Patients: A Multicenter Retrospective StudyNicholas R Pettit, Matthew Hays, Xiaochun Li, et al.
The Journal of Emergency Medicine|July 4, 2025
Evaluating the Impact of a Novel Referral Pathway for Suspected Cancer Cases in Emergency Department PatientsNicholas R Pettit, Eli Martinez, Marissa Vander-Missen, et al.
Cancer Research|June 15, 1989
Comparison of effects of bryostatins 1 and 2 and 12-O-tetradecanoylphorbol-13-acetate on protein kinase C activity in A549 human lung carcinoma cellsI L Dale, T D Bradshaw, A Gescher, et al.
Leukemia|May 1, 1992
Effect of a combined exposure to cytosine arabinoside, bryostatin 1, and recombinant granulocyte-macrophage colony-stimulating factor on the clonogenic growth in vitro of normal and leukemic human hematopoietic progenitor cellsS Grant, R Traylor, K Bhalla, et al.
Journal of Medicinal Chemistry|December 1, 1990
Chiral modifications of dolastatin 10: the potent cytostatic peptide (19aR)-isodolastatin 10G R Pettit, S B Singh, F Hogan, et al.
Molecular Pharmacology|January 5, 2000
Sustained intracellular retention of dolastatin 10 causes its potent antimitotic activityP Verdier-Pinard, J A Kepler, G R Pettit, et al.
The Journal of Biological Chemistry|January 21, 1994
Differential regulation of protein kinase C isozymes by bryostatin 1 and phorbol 12-myristate 13-acetate in NIH 3T3 fibroblastsZ Szallasi, C B Smith, G R Pettit, et al.
Pageof 66

Showing results (201-210 of 659) with videos related to

Sort By:
Pageof 66
Journal of Chemotherapy (Florence, Italy)|March 18, 2008
In vitro interactions of approved and experimental drugs against Candida drugs against Candida sppK K Repp, F Hogan, G R Pettit, et al.
Molecular Pharmacology|March 1, 1997
Bryostatin 1 and phorbol ester down-modulate protein kinase C-alpha and -epsilon via the ubiquitin/proteasome pathway in human fibroblastsH W Lee, L Smith, G R Pettit, et al.
Anticancer Research|June 6, 1998
Dolastatin 15 induces apoptosis and BCL-2 phosphorylation in small cell lung cancer cell linesM A Ali, R Rosati, G R Pettit, et al.
Cancer Investigation|February 2, 2026
Low Cancer Screening Rates Among Emergency Department Patients: A Multicenter Retrospective StudyNicholas R Pettit, Matthew Hays, Xiaochun Li, et al.
The Journal of Emergency Medicine|July 4, 2025
Evaluating the Impact of a Novel Referral Pathway for Suspected Cancer Cases in Emergency Department PatientsNicholas R Pettit, Eli Martinez, Marissa Vander-Missen, et al.
Cancer Research|June 15, 1989
Comparison of effects of bryostatins 1 and 2 and 12-O-tetradecanoylphorbol-13-acetate on protein kinase C activity in A549 human lung carcinoma cellsI L Dale, T D Bradshaw, A Gescher, et al.
Leukemia|May 1, 1992
Effect of a combined exposure to cytosine arabinoside, bryostatin 1, and recombinant granulocyte-macrophage colony-stimulating factor on the clonogenic growth in vitro of normal and leukemic human hematopoietic progenitor cellsS Grant, R Traylor, K Bhalla, et al.
Journal of Medicinal Chemistry|December 1, 1990
Chiral modifications of dolastatin 10: the potent cytostatic peptide (19aR)-isodolastatin 10G R Pettit, S B Singh, F Hogan, et al.
Molecular Pharmacology|January 5, 2000
Sustained intracellular retention of dolastatin 10 causes its potent antimitotic activityP Verdier-Pinard, J A Kepler, G R Pettit, et al.
The Journal of Biological Chemistry|January 21, 1994
Differential regulation of protein kinase C isozymes by bryostatin 1 and phorbol 12-myristate 13-acetate in NIH 3T3 fibroblastsZ Szallasi, C B Smith, G R Pettit, et al.
Pageof 66